|
Thursday 26 April 2007
Puppy Prozac to help stressed pets
Last Updated: 4:15am BST 25/04/2007
If your doberman is a little down in the mouth or your
poodle a bit peaky, help is at hand from the makers of
Prozac who have developed the drug for dogs, with the canine
version coming in chewable form and tasty beef flavour.
It's a dog's life. The canine anti- depressant is
called Reconcile
|
The anti-depressant is being launched to the pet market
by drug company Eli Lilly to treat dogs which bark
incessantly or chew furniture when left alone.
The reformulated form of Prozac, or as it is called
generically fluoxetine, will be marketed under the name
Reconcile. It is the first drug to be marketed by a new
division of Eli Lilly, which is to be devoted entirely to
pet pharmaceuticals.
Clinical trials showed that the drug significantly
reduced the symptoms of separation anxiety in dogs, which is
estimated to affect between 10 to 20 per cent of domestic
dogs.
The symptoms include the dog going berserk, barking,
howling, ripping up carpets and destroying furniture and
incessant scratching at the door to get out. Several
complementary products targeted at the sufferers of the
condition are already on the market.
But Dr Roger Mugford, a leading animal psychologist, said
vets were not keen on the development of drugs to treat
animal behaviour, a view expressed at a recent meeting in
Birmingham of the British Small Animal Veterinary
Association.
"A number of speakers, including me, were all of one mind
that pharmacological help with any anti-depressant or mood
modifying drugs diminishes the better you are at your
behavioural management," he said.
"The more skilful you are at behaviour modification, at
getting the animal husbandry right - diet, exercise,
lifestyle and so on, the less the need for drugs."
Dr Mugford said there were also concerns that Prozac had
some unpleasant side effects in humans, which could suggest
that some dogs might become aggressive when taking it.
"Why do we need these things? It is so easy to modify
the behaviour of dogs by good management techniques. We
call it behavioural husbandry," he said.
The company is also planning to develop other drugs for
the pet market, in particular some slimming products which
failed to pass trials for use in people.
"If Eli Lilly want to dust off old patents on products
that were not suitable for humans, I doubt that it would
work," added Dr Mugford, who runs the Animal Behaviour
Centre at Chertsey, Surrey.
|